This journal has adopted the following models:
- Creative Commons Attribution License (CC-BY 2.0 UK)
- Publication Integrity and Ethics (P.I.E.) Guidelines
- Ethical Rules of Disclosure of the Association for Medical Ethics (AME)
- ICMJE Recommendations of the International Committee of Medical Journal Editors (ICMJE)
- Editorial Policy Statements of the Council of Science Editors (CSE)
Tracked/indexed by:
Google Scholar, JournalSeek, CrossRef, EZB Nutzeranfragen, RoMEO, AcademicKeys, CNKI, J-Gate
OAPL (UK) archiving provider: British Library
Our publisher has negotiated a discount for its editors, reviewers and authors to undertake (distant learning- fully online) short courses related to research integrity and publication ethics, law and medical ethics, research governance, good ethical practice, leadership and management. These courses are approved by the Publication Integrity & Ethics.
A UK-based not-for-profit organization promoting integrity and ethics in the publishing sector through its guidelines and code of conduct.
P.I.E.'s main aim is to pave the way for a better publishing ethical environment that sets out the standards of a good and ethical editorial behaviour.
Whilst P.I.E. (π) promotes editorial freedom, at the same time, it also ensures that this freedom is not violated by editorial misconduct and plagiarism.
OAPL authors may choose to include the
OAPL standard ethics statements
in their submitted articles. It is assumed that all submitted original research studies, research studies, hypothesis, methodologies, short communications, case studies, case reports & case series have been conducted to the highest ethical standards.
Kanda E. Causes of fever in dialysis patients and its treatment. OA Nephrology 2014 Mar 09;2(1):4.
High Impact
Gulleroglu K, Baskin E, Gulleroglu B. Atypical haemolytic uraemic syndrome. OA Nephrology 2014 Feb 24;2(1):3.
High Impact
Wang Z, Dou Y, Liu D, Xiao J, Zhao Z. The interaction of fluid status and residual renal function in peritoneal dialysis patients. OA Nephrology 2014 Jan 18;2(1):2.
High Impact
Hayashi M, Izawa H. Recent prophylactic strategies and novel biomarkers for contrast-induced acute kidney injury. OA Nephrology 2014 Jan 18;2(1):1.
High Impact
Murakami CA, Sozio SM. Uric acid in chronic kidney disease. OA Nephrology 2013 Dec 30;1(3):22.
High Impact
Fox CH, Neuhaus K, Vassalotti JA. Importance of urine albumincreatinine ratio in the diagnosis and prognosis of chronic kidney disease. OA Nephrology 2013 Nov 01;1(3):21.
High Impact
Schiffl H, Lang SM. Improvement of all-cause mortality with high-efficiency post-dilution online haemodiafiltration: is this standard care for ESRD patients? OA Nephrology 2013 Nov 01;1(2):20.
High Impact
Fujita T. Extra-immunological role of complement activation in diabetic nephropathy. OA Nephrology 2013 Oct 25;1(2):19.
High Impact
Johns TS, Crews DC. Racial and socioeconomic disparities in end-stage renal disease in the United States. OA Nephrology 2013 Oct 17;1(2):18.
High Impact
Forbes SH, Ashman N, Yaqoob MM. The role of platelets in the prognosis of renal disease. OA Nephrology 2013 Sep 01;1(2):17.
High Impact
Naushabayeva A, Abeuova B, Chingayeva G, Kabulbayev K, Nurbekova A, Nugmanova A, Smagulova A, Kanatbayeva A. Focal segmental glomerulosclerosis variants in children with nephrotic syndrome. OA Nephrology 2013 Sep 01;1(2):16.
High Impact
Lai S, Mariotti A, Lai C, Testorio M, Carta M, Innico G, Frassetti N, Russo GE. Nephropathies in HIV-infected patients: an overview. OA Nephrology 2013 Aug 01;1(2):15.
High Impact
Ravnskov U. The crucial role of tubulotoxic chemicals in renal failure. OA Nephrology 2013 Aug 01;1(2):14.
High Impact
Kanda E. Causes of fever in dialysis patients and its treatment. OA Nephrology 2014 Mar 09;2(1):4.
High Impact
Forbes SH, Ashman N, Yaqoob MM. The role of platelets in the prognosis of renal disease. OA Nephrology 2013 Sep 01;1(2):17.
High Impact
Hirayama K, Yamagata K. The anti-GBM disease: treatments and outcomes. OA Nephrology 2013 Apr 01;1(1):1.
High Impact
Medrano AS, Jaller KR. The current evidence supporting rituximab treatment in primary glomerular diseases causing nephrotic syndrome: Critical review. OA Nephrology 2013 Apr 01;1(1):3.
High Impact
Golay V, Roychowdhury A. The percutaneous native kidney biopsy: a nephrologists perspective. OA Nephrology 2013 May 27;1(1):8.
High Impact
Fujita T. Extra-immunological role of complement activation in diabetic nephropathy. OA Nephrology 2013 Oct 25;1(2):19.
High Impact
Johns TS, Crews DC. Racial and socioeconomic disparities in end-stage renal disease in the United States. OA Nephrology 2013 Oct 17;1(2):18.
High Impact
Kan WC, Wang JJ, Sun YM, Hung CY, Chu CC, Chien CC. The comorbidity scoring systems for predicting survival in elderly dialysis patients and additional management strategies. OA Nephrology 2013 Jul 01;1(2):12.
High Impact
Lai S, Mariotti A, Lai C, Testorio M, Carta M, Innico G, Frassetti N, Russo GE. Nephropathies in HIV-infected patients: an overview. OA Nephrology 2013 Aug 01;1(2):15.
High Impact
Murakami CA, Sozio SM. Uric acid in chronic kidney disease. OA Nephrology 2013 Dec 30;1(3):22.
High Impact
Rossi M, Campbell KL, Johnson DW. Indoxyl sulphate and p-cresyl sulphate: therapeutically modifiable nephrovascular toxins. OA Nephrology 2013 Jul 01;1(2):13.
High Impact
Fox CH, Neuhaus K, Vassalotti JA. Importance of urine albumincreatinine ratio in the diagnosis and prognosis of chronic kidney disease. OA Nephrology 2013 Nov 01;1(3):21.
High Impact
Afsar B. Dyslipidemias in chronic kidney disease: Current guidelines and future perspectives. OA Nephrology 2013 Apr 01;1(1):2.
High Impact
Kanda E. Causes of fever in dialysis patients and its treatment. OA Nephrology 2014 Mar 09;2(1):4.
High Impact
Gulleroglu K, Baskin E, Gulleroglu B. Atypical haemolytic uraemic syndrome. OA Nephrology 2014 Feb 24;2(1):3.
High Impact
Wang Z, Dou Y, Liu D, Xiao J, Zhao Z. The interaction of fluid status and residual renal function in peritoneal dialysis patients. OA Nephrology 2014 Jan 18;2(1):2.
High Impact
Hayashi M, Izawa H. Recent prophylactic strategies and novel biomarkers for contrast-induced acute kidney injury. OA Nephrology 2014 Jan 18;2(1):1.
High Impact
Murakami CA, Sozio SM. Uric acid in chronic kidney disease. OA Nephrology 2013 Dec 30;1(3):22.
High Impact
Fox CH, Neuhaus K, Vassalotti JA. Importance of urine albumincreatinine ratio in the diagnosis and prognosis of chronic kidney disease. OA Nephrology 2013 Nov 01;1(3):21.
High Impact
Schiffl H, Lang SM. Improvement of all-cause mortality with high-efficiency post-dilution online haemodiafiltration: is this standard care for ESRD patients? OA Nephrology 2013 Nov 01;1(2):20.
High Impact
Fujita T. Extra-immunological role of complement activation in diabetic nephropathy. OA Nephrology 2013 Oct 25;1(2):19.
High Impact
Johns TS, Crews DC. Racial and socioeconomic disparities in end-stage renal disease in the United States. OA Nephrology 2013 Oct 17;1(2):18.
High Impact
Forbes SH, Ashman N, Yaqoob MM. The role of platelets in the prognosis of renal disease. OA Nephrology 2013 Sep 01;1(2):17.
High Impact
Naushabayeva A, Abeuova B, Chingayeva G, Kabulbayev K, Nurbekova A, Nugmanova A, Smagulova A, Kanatbayeva A. Focal segmental glomerulosclerosis variants in children with nephrotic syndrome. OA Nephrology 2013 Sep 01;1(2):16.
High Impact
Lai S, Mariotti A, Lai C, Testorio M, Carta M, Innico G, Frassetti N, Russo GE. Nephropathies in HIV-infected patients: an overview. OA Nephrology 2013 Aug 01;1(2):15.
High Impact
Ravnskov U. The crucial role of tubulotoxic chemicals in renal failure. OA Nephrology 2013 Aug 01;1(2):14.
High Impact
